Corrigendum to “Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway” [Redox Biol. 52 (2022) 102288] (Redox Biology (2022) 52, (S221323172200060X), (10.1016/j.redox.2022.102288))

After publication of the article, the authors found the two images were mistakenly renamed and placed into incorrect files. We assure that this was an honest oversight and no intentional change of images has been made. During the assembly of figures, we mistakenly presented the picture of the sham + EMPA group in Fig. 1A as a duplicate in Fig. 5A. The corrected pictures of Fig. 1A are shown below and the scientific conclusion was unaffected because there was no statistical analysis conducted on Figs. 1A and 5A. Additionally, in Fig. 4I, the loading control ULK1 was erroneously presented during the picture assembly and the corrected picture of ULK1 in Fig. 4I is shown below. Since the statistical analysis for Fig. 4I was based on the alterations of p-ULK1, the statistical analysis was not affected. So, the scientific conclusion of our article remains valid. The authors would like to apologize for any inconvenience caused.[Formula